Figure 1.
The location of cerebral microbleeds (CMBs) on 3D-enhanced T2*-weighted gradient echo sequence of MRI (arrows).
(A) CMBs in frontal lobe. (B) CMBs in thalamus.
Figure 2.
White matter hyperintensities on T2-fluid-attenuated inversion recovery sequence (T2-FLAIR).
Deep white matter hyperintensities (DWMH) and peri-ventricular hyperintensities (PVH) was indicated by arrow and arrow head, respectively.
Table 1.
Clinical Characteristics.
Table 2.
Risk Factors for CMBs, PVH, DWMH and LI (OR, 95% CI).
Figure 3.
The relationship between cerebral microbleeds (CMBs) and white matter hyperintensities.
The proportion of patients with CMBs increased with the severity of deep white matter hyperintensities (DWMH) (p<0.001, χ2 test) and peri-ventricular hyperintensities (PVH) (p<0.001, χ2 test). Each bar represents the number of patients.
Table 3.
Correlations amongst CMBs, WML, LI and risk factors (r).
Table 4.
Correlation between the presence of CMBs and PVH, DWMH stratified by hypertension(r).
Table 5.
Correlation between the distribution of CMBs and presence of PVH, DWMH (%, n).
Table 6.
Correlation between the severity of CMBs and presence of PVH, DWMH (%, n).